Adult-onset Still's disease (AOSD) is a rare inflammatory disorder. Thanks to a new initiative, AOSD is now considered to be the adult counterpart of systemic juvenile idiopathic arthritis, but in ...
Findings showed that 53.8% of patients treated with emapalumab achieved a complete response. The Food and Drug Administration (FDA) has approved Gamifant ® (emapalumab-lzsg) for the treatment of adult ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results